Dorsey Wright & Associates Oramed Pharmaceuticals Inc. Transaction History

Dorsey Wright & Associates

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$12.98 - $29.75 $71,623 - $164,160	-5,518 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$12.13 - $23.82 $5,240 - $10,290	432 Added 8.49%	5,518 $121,000
Q1 2021 Apr 27, 2021	BUY	$4.22 - $11.33 $21,462 - $57,624	5,086 New	5,086 $51.7 Million

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.